Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Observational Studies01:11

Observational Studies

Observational studies are a type of analytical study where researchers observe events without any interventions. In other words, the researcher does not influence the response variable or the experiment's outcome.
There are three types of observational studies – Prospective, retrospective, and cross-sectional.
Prospective Study
Prospective studies, also known as longitudinal or cohort studies, are carried out by collecting future data from groups sharing similar characteristics. One example of...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An essential goal within reach: attaining diversity, equity, and inclusion for the Journal of the National Cancer Institute journals.

JNCI cancer spectrum·2023
Same author

Intervention Nonadherence in the TrACER (S1415CD) Study: A Pragmatic Randomized Trial of a Standardized Order Entry for CSF Prescribing.

JCO oncology practice·2023
Same author

Impact of treatment experience on patient knowledge of colony-stimulating factors among patients receiving cancer chemotherapy: evidence from S1415CD-a large pragmatic trial.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2023
Same author

Universal Viral Screening of Patients with Newly Diagnosed Cancer in the United States: A Cost-efficiency Evaluation.

Cancer research communications·2023
Same author

Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA.32: A Secondary Analysis of a Phase III Randomized Double-Blind Trial in Early Breast Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023
Same author

Disparities with influenza vaccine use in long-term survivors of metastatic breast cancer.

Breast cancer research and treatment·2023

Related Experiment Video

Updated: May 17, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Comparative effectiveness research in oncology methodology: observational data.

Dawn L Hershman1, Jason D Wright

  • 1Columbia University Medical Center and the Herbert Irving Comprehensive Cancer Center, New York, NY, USA. dlh23@columbia.edu

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|October 17, 2012
PubMed
Summary
This summary is machine-generated.

Comparative effectiveness research uses real-world data to guide treatment choices and improve patient outcomes. Observational studies and administrative data offer valuable insights where randomized trials fall short.

Related Experiment Videos

Last Updated: May 17, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Area of Science:

  • Health Services Research
  • Clinical Epidemiology
  • Comparative Effectiveness Research

Background:

  • Randomized controlled trials (RCTs) provide limited evidence for real-world patient populations.
  • Observational studies using population-based registry data are crucial for filling evidence gaps.
  • Administrative data offer large sample sizes, long-term follow-up, and system-level insights.

Purpose of the Study:

  • To review commonly used population-based data sets for comparative effectiveness research.
  • To discuss research themes and analytic techniques for observational studies.
  • To highlight the strengths and limitations of observational research in informing clinical decisions and health policy.

Main Methods:

  • Review of characteristics of commonly used population-based data sets.
  • Overview of research themes and examples utilizing population-based data.
  • Discussion of analytic techniques to mitigate bias and confounding in observational studies.

Main Results:

  • Population-based data sets and administrative data are valuable resources for comparative effectiveness research.
  • Sophisticated analytic techniques can enhance the accuracy of nonrandomized studies.
  • Well-designed observational studies can significantly inform medical decision-making and health policy.

Conclusions:

  • Observational studies, when carefully designed and analyzed, can reliably inform clinical decisions.
  • Understanding the opportunities, strengths, and limitations of observational research is critical.
  • Real-world data from observational studies are essential for improving patient outcomes and health policy.